Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors

Discover the groundbreaking insights in "Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors," published by John Wiley & Sons Inc in 2006. This comprehensive hardback edition spans 384 pages and delves into the significant role of GSK-3 as a promising drug target. With extensive testing backing its potential, this book explores how GSK-3 inhibitors may offer hope for treating challenging diseases, including Alzheimer's, bipolar disorder, and cancer—conditions that currently lack effective therapies. Ideal for researchers, healthcare professionals, and anyone interested in innovative treatments, this book provides a thorough understanding of GSK-3 and its implications in modern medicine. Enhance your knowledge and explore the future of therapeutic possibilities with this essential resource.